Cargando…

Characterization of a canine model of glycogen storage disease type IIIa

Glycogen storage disease type IIIa (GSD IIIa) is an autosomal recessive disease caused by deficiency of glycogen debranching enzyme (GDE) in liver and muscle. The disorder is clinically heterogeneous and progressive, and there is no effective treatment. Previously, a naturally occurring dog model fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Haiqing, Thurberg, Beth L., Curtis, Sarah, Austin, Stephanie, Fyfe, John, Koeberl, Dwight D., Kishnani, Priya S., Sun, Baodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Limited 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484863/
https://www.ncbi.nlm.nih.gov/pubmed/22736456
http://dx.doi.org/10.1242/dmm.009712
_version_ 1782248201406906368
author Yi, Haiqing
Thurberg, Beth L.
Curtis, Sarah
Austin, Stephanie
Fyfe, John
Koeberl, Dwight D.
Kishnani, Priya S.
Sun, Baodong
author_facet Yi, Haiqing
Thurberg, Beth L.
Curtis, Sarah
Austin, Stephanie
Fyfe, John
Koeberl, Dwight D.
Kishnani, Priya S.
Sun, Baodong
author_sort Yi, Haiqing
collection PubMed
description Glycogen storage disease type IIIa (GSD IIIa) is an autosomal recessive disease caused by deficiency of glycogen debranching enzyme (GDE) in liver and muscle. The disorder is clinically heterogeneous and progressive, and there is no effective treatment. Previously, a naturally occurring dog model for this condition was identified in curly-coated retrievers (CCR). The affected dogs carry a frame-shift mutation in the GDE gene and have no detectable GDE activity in liver and muscle. We characterized in detail the disease expression and progression in eight dogs from age 2 to 16 months. Monthly blood biochemistry revealed elevated and gradually increasing serum alanine transaminase (ALT), aspartate transaminase (AST) and alkaline phosphatase (ALP) activities; serum creatine phosphokinase (CPK) activity exceeded normal range after 12 months. Analysis of tissue biopsy specimens at 4, 12 and 16 months revealed abnormally high glycogen contents in liver and muscle of all dogs. Fasting liver glycogen content increased from 4 months to 12 months, but dropped at 16 months possibly caused by extended fibrosis; muscle glycogen content continually increased with age. Light microscopy revealed significant glycogen accumulation in hepatocytes at all ages. Liver histology showed progressive, age-related fibrosis. In muscle, scattered cytoplasmic glycogen deposits were present in most cells at 4 months, but large, lake-like accumulation developed by 12 and 16 months. Disruption of the contractile apparatus and fraying of myofibrils was observed in muscle at 12 and 16 months by electron microscopy. In conclusion, the CCR dogs are an accurate model of GSD IIIa that will improve our understanding of the disease progression and allow opportunities to investigate treatment interventions.
format Online
Article
Text
id pubmed-3484863
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Company of Biologists Limited
record_format MEDLINE/PubMed
spelling pubmed-34848632012-11-16 Characterization of a canine model of glycogen storage disease type IIIa Yi, Haiqing Thurberg, Beth L. Curtis, Sarah Austin, Stephanie Fyfe, John Koeberl, Dwight D. Kishnani, Priya S. Sun, Baodong Dis Model Mech Research Article Glycogen storage disease type IIIa (GSD IIIa) is an autosomal recessive disease caused by deficiency of glycogen debranching enzyme (GDE) in liver and muscle. The disorder is clinically heterogeneous and progressive, and there is no effective treatment. Previously, a naturally occurring dog model for this condition was identified in curly-coated retrievers (CCR). The affected dogs carry a frame-shift mutation in the GDE gene and have no detectable GDE activity in liver and muscle. We characterized in detail the disease expression and progression in eight dogs from age 2 to 16 months. Monthly blood biochemistry revealed elevated and gradually increasing serum alanine transaminase (ALT), aspartate transaminase (AST) and alkaline phosphatase (ALP) activities; serum creatine phosphokinase (CPK) activity exceeded normal range after 12 months. Analysis of tissue biopsy specimens at 4, 12 and 16 months revealed abnormally high glycogen contents in liver and muscle of all dogs. Fasting liver glycogen content increased from 4 months to 12 months, but dropped at 16 months possibly caused by extended fibrosis; muscle glycogen content continually increased with age. Light microscopy revealed significant glycogen accumulation in hepatocytes at all ages. Liver histology showed progressive, age-related fibrosis. In muscle, scattered cytoplasmic glycogen deposits were present in most cells at 4 months, but large, lake-like accumulation developed by 12 and 16 months. Disruption of the contractile apparatus and fraying of myofibrils was observed in muscle at 12 and 16 months by electron microscopy. In conclusion, the CCR dogs are an accurate model of GSD IIIa that will improve our understanding of the disease progression and allow opportunities to investigate treatment interventions. The Company of Biologists Limited 2012-11 2012-06-26 /pmc/articles/PMC3484863/ /pubmed/22736456 http://dx.doi.org/10.1242/dmm.009712 Text en © 2012. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
spellingShingle Research Article
Yi, Haiqing
Thurberg, Beth L.
Curtis, Sarah
Austin, Stephanie
Fyfe, John
Koeberl, Dwight D.
Kishnani, Priya S.
Sun, Baodong
Characterization of a canine model of glycogen storage disease type IIIa
title Characterization of a canine model of glycogen storage disease type IIIa
title_full Characterization of a canine model of glycogen storage disease type IIIa
title_fullStr Characterization of a canine model of glycogen storage disease type IIIa
title_full_unstemmed Characterization of a canine model of glycogen storage disease type IIIa
title_short Characterization of a canine model of glycogen storage disease type IIIa
title_sort characterization of a canine model of glycogen storage disease type iiia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484863/
https://www.ncbi.nlm.nih.gov/pubmed/22736456
http://dx.doi.org/10.1242/dmm.009712
work_keys_str_mv AT yihaiqing characterizationofacaninemodelofglycogenstoragediseasetypeiiia
AT thurbergbethl characterizationofacaninemodelofglycogenstoragediseasetypeiiia
AT curtissarah characterizationofacaninemodelofglycogenstoragediseasetypeiiia
AT austinstephanie characterizationofacaninemodelofglycogenstoragediseasetypeiiia
AT fyfejohn characterizationofacaninemodelofglycogenstoragediseasetypeiiia
AT koeberldwightd characterizationofacaninemodelofglycogenstoragediseasetypeiiia
AT kishnanipriyas characterizationofacaninemodelofglycogenstoragediseasetypeiiia
AT sunbaodong characterizationofacaninemodelofglycogenstoragediseasetypeiiia